KR20190055159A - 사용 및 비강내 시스템으로의 전달을 위한 암모니아 산화 미생물 - Google Patents

Info

Publication number

KR20190055159A

KR20190055159A KR1020197010958A KR20197010958A KR20190055159A KR 20190055159 A KR20190055159 A KR 20190055159A KR 1020197010958 A KR1020197010958 A KR 1020197010958A KR 20197010958 A KR20197010958 A KR 20197010958A KR 20190055159 A KR20190055159 A KR 20190055159A

Authority

KR

South Korea

Prior art keywords

subject

agent

aom

administered

formulation

Prior art date

2016-09-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 244000005700 microbiome Species 0.000 title claims abstract description 220
• 238000012384 transportation and delivery Methods 0.000 title claims abstract description 54
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 478
• 229910021529 ammonia Inorganic materials 0.000 claims abstract description 239
• 230000001590 oxidative effect Effects 0.000 claims abstract description 197
• 238000000034 method Methods 0.000 claims abstract description 159
• 238000002360 preparation method Methods 0.000 claims abstract description 66
• 208000012902 Nervous system disease Diseases 0.000 claims abstract description 30
• 208000026344 Nasal disease Diseases 0.000 claims abstract description 19
• 208000030880 Nose disease Diseases 0.000 claims abstract description 19
• 208000028347 Sinus disease Diseases 0.000 claims abstract description 19
• 208000018920 Paranasal Sinus disease Diseases 0.000 claims abstract description 18
• 239000000203 mixture Substances 0.000 claims description 343
• 238000009472 formulation Methods 0.000 claims description 206
• 239000003795 chemical substances by application Substances 0.000 claims description 159
• 210000001519 tissue Anatomy 0.000 claims description 99
• 238000011282 treatment Methods 0.000 claims description 93
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 77
• IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 53
• 208000035475 disorder Diseases 0.000 claims description 48
• 241000894006 Bacteria Species 0.000 claims description 46
• 239000000843 powder Substances 0.000 claims description 44
• 206010057190 Respiratory tract infections Diseases 0.000 claims description 40
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 38
• 230000000694 effects Effects 0.000 claims description 38
• 210000003928 nasal cavity Anatomy 0.000 claims description 38
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 38
• 239000000243 solution Substances 0.000 claims description 37
• -1 buccal Substances 0.000 claims description 36
• 230000009885 systemic effect Effects 0.000 claims description 36
• 239000000499 gel Substances 0.000 claims description 33
• 239000007788 liquid Substances 0.000 claims description 33
• 206010061218 Inflammation Diseases 0.000 claims description 29
• 201000010099 disease Diseases 0.000 claims description 29
• 230000004054 inflammatory process Effects 0.000 claims description 29
• 206010012689 Diabetic retinopathy Diseases 0.000 claims description 26
• 239000007921 spray Substances 0.000 claims description 26
• 239000000443 aerosol Substances 0.000 claims description 25
• 230000004968 inflammatory condition Effects 0.000 claims description 25
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
• 230000012010 growth Effects 0.000 claims description 24
• 108090000623 proteins and genes Proteins 0.000 claims description 23
• 229910001868 water Inorganic materials 0.000 claims description 23
• 239000004202 carbamide Substances 0.000 claims description 20
• 231100000869 headache Toxicity 0.000 claims description 19
• 208000033808 peripheral neuropathy Diseases 0.000 claims description 19
• 239000004094 surface-active agent Substances 0.000 claims description 19
• 206010019233 Headaches Diseases 0.000 claims description 18
• 239000002552 dosage form Substances 0.000 claims description 17
• 239000000463 material Substances 0.000 claims description 17
• 230000004087 circulation Effects 0.000 claims description 16
• 239000006196 drop Substances 0.000 claims description 16
• 208000015181 infectious disease Diseases 0.000 claims description 16
• 238000010521 absorption reaction Methods 0.000 claims description 15
• 230000002530 ischemic preconditioning effect Effects 0.000 claims description 15
• 239000003595 mist Substances 0.000 claims description 15
• 102000004169 proteins and genes Human genes 0.000 claims description 15
• 239000000725 suspension Substances 0.000 claims description 15
• 206010020772 Hypertension Diseases 0.000 claims description 14
• 208000007920 Neurogenic Inflammation Diseases 0.000 claims description 14
• 208000025966 Neurological disease Diseases 0.000 claims description 13
• 210000003169 central nervous system Anatomy 0.000 claims description 13
• 239000000839 emulsion Substances 0.000 claims description 13
• 239000000314 lubricant Substances 0.000 claims description 13
• 238000004519 manufacturing process Methods 0.000 claims description 13
• 239000011734 sodium Substances 0.000 claims description 13
• 206010039085 Rhinitis allergic Diseases 0.000 claims description 12
• 206010040744 Sinus headache Diseases 0.000 claims description 12
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
• 201000010105 allergic rhinitis Diseases 0.000 claims description 12
• 150000001875 compounds Chemical class 0.000 claims description 12
• 201000001119 neuropathy Diseases 0.000 claims description 12
• 230000007823 neuropathy Effects 0.000 claims description 12
• 239000008194 pharmaceutical composition Substances 0.000 claims description 12
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 11
• 239000007853 buffer solution Substances 0.000 claims description 11
• 239000002674 ointment Substances 0.000 claims description 11
• 238000001356 surgical procedure Methods 0.000 claims description 11
• 210000001944 turbinate Anatomy 0.000 claims description 11
• 208000035143 Bacterial infection Diseases 0.000 claims description 10
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
• 229910002651 NO3 Inorganic materials 0.000 claims description 10
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 10
• 241000605122 Nitrosomonas Species 0.000 claims description 10
• 239000012062 aqueous buffer Substances 0.000 claims description 10
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 10
• 239000002738 chelating agent Substances 0.000 claims description 10
• 210000002850 nasal mucosa Anatomy 0.000 claims description 10
• 201000011461 pre-eclampsia Diseases 0.000 claims description 10
• 239000003755 preservative agent Substances 0.000 claims description 10
• 239000003981 vehicle Substances 0.000 claims description 10
• 201000001320 Atherosclerosis Diseases 0.000 claims description 9
• 239000000945 filler Substances 0.000 claims description 9
• 230000004060 metabolic process Effects 0.000 claims description 9
• 230000003232 mucoadhesive effect Effects 0.000 claims description 9
• 230000002265 prevention Effects 0.000 claims description 9
• 239000002904 solvent Substances 0.000 claims description 9
• 238000002560 therapeutic procedure Methods 0.000 claims description 9
• 230000000699 topical effect Effects 0.000 claims description 9
• 208000024172 Cardiovascular disease Diseases 0.000 claims description 8
• 208000032131 Diabetic Neuropathies Diseases 0.000 claims description 8
• 208000001647 Renal Insufficiency Diseases 0.000 claims description 8
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 8
• 208000036142 Viral infection Diseases 0.000 claims description 8
• 206010003246 arthritis Diseases 0.000 claims description 8
• 239000003623 enhancer Substances 0.000 claims description 8
• 230000035876 healing Effects 0.000 claims description 8
• 206010022437 insomnia Diseases 0.000 claims description 8
• 201000006370 kidney failure Diseases 0.000 claims description 8
• 230000036542 oxidative stress Effects 0.000 claims description 8
• 230000035515 penetration Effects 0.000 claims description 8
• 208000019901 Anxiety disease Diseases 0.000 claims description 7
• 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims description 7
• 208000001640 Fibromyalgia Diseases 0.000 claims description 7
• 206010017533 Fungal infection Diseases 0.000 claims description 7
• 206010019663 Hepatic failure Diseases 0.000 claims description 7
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
• 208000001145 Metabolic Syndrome Diseases 0.000 claims description 7
• 208000019695 Migraine disease Diseases 0.000 claims description 7
• 208000008589 Obesity Diseases 0.000 claims description 7
• 206010033645 Pancreatitis Diseases 0.000 claims description 7
• 108010046334 Urease Proteins 0.000 claims description 7
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 7
• 230000036506 anxiety Effects 0.000 claims description 7
• 208000006673 asthma Diseases 0.000 claims description 7
• 239000003086 colorant Substances 0.000 claims description 7
• 238000002648 combination therapy Methods 0.000 claims description 7
• 238000013270 controlled release Methods 0.000 claims description 7
• 239000007884 disintegrant Substances 0.000 claims description 7
• 208000007903 liver failure Diseases 0.000 claims description 7
• 231100000835 liver failure Toxicity 0.000 claims description 7
• 206010027599 migraine Diseases 0.000 claims description 7
• 201000006417 multiple sclerosis Diseases 0.000 claims description 7
• 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims description 7
• 239000007922 nasal spray Substances 0.000 claims description 7
• 235000020824 obesity Nutrition 0.000 claims description 7
• 208000028173 post-traumatic stress disease Diseases 0.000 claims description 7
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 7
• 208000017520 skin disease Diseases 0.000 claims description 7
• 229910052708 sodium Inorganic materials 0.000 claims description 7
• 239000000375 suspending agent Substances 0.000 claims description 7
• 230000029663 wound healing Effects 0.000 claims description 7
• 208000023275 Autoimmune disease Diseases 0.000 claims description 6
• 208000018672 Dilatation Diseases 0.000 claims description 6
• 206010019280 Heart failures Diseases 0.000 claims description 6
• 208000031888 Mycoses Diseases 0.000 claims description 6
• 208000018262 Peripheral vascular disease Diseases 0.000 claims description 6
• 201000009594 Systemic Scleroderma Diseases 0.000 claims description 6
• 206010042953 Systemic sclerosis Diseases 0.000 claims description 6
• 150000003863 ammonium salts Chemical class 0.000 claims description 6
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 6
• 239000000730 antalgic agent Substances 0.000 claims description 6
• 239000003963 antioxidant agent Substances 0.000 claims description 6
• 239000011230 binding agent Substances 0.000 claims description 6
• 230000003115 biocidal effect Effects 0.000 claims description 6
• 239000000872 buffer Substances 0.000 claims description 6
• 230000005961 cardioprotection Effects 0.000 claims description 6
• 208000027744 congestion Diseases 0.000 claims description 6
• 206010015037 epilepsy Diseases 0.000 claims description 6
• 208000006454 hepatitis Diseases 0.000 claims description 6
• 231100000283 hepatitis Toxicity 0.000 claims description 6
• 239000000017 hydrogel Substances 0.000 claims description 6
• 230000028993 immune response Effects 0.000 claims description 6
• 208000019423 liver disease Diseases 0.000 claims description 6
• 210000003097 mucus Anatomy 0.000 claims description 6
• 208000007232 portal hypertension Diseases 0.000 claims description 6
• 230000002829 reductive effect Effects 0.000 claims description 6
• 230000004044 response Effects 0.000 claims description 6
• 201000009890 sinusitis Diseases 0.000 claims description 6
• 239000011780 sodium chloride Substances 0.000 claims description 6
• 210000003718 sphenoid sinus Anatomy 0.000 claims description 6
• 239000002562 thickening agent Substances 0.000 claims description 6
• 230000009385 viral infection Effects 0.000 claims description 6
• 208000024827 Alzheimer disease Diseases 0.000 claims description 5
• 206010070538 Gestational hypertension Diseases 0.000 claims description 5
• 241001495394 Nitrosospira Species 0.000 claims description 5
• 230000008859 change Effects 0.000 claims description 5
• 208000018631 connective tissue disease Diseases 0.000 claims description 5
• 238000009792 diffusion process Methods 0.000 claims description 5
• 208000002296 eclampsia Diseases 0.000 claims description 5
• 238000013265 extended release Methods 0.000 claims description 5
• 239000000796 flavoring agent Substances 0.000 claims description 5
• 210000005095 gastrointestinal system Anatomy 0.000 claims description 5
• 208000004104 gestational diabetes Diseases 0.000 claims description 5
• 229910001629 magnesium chloride Inorganic materials 0.000 claims description 5
• 239000003094 microcapsule Substances 0.000 claims description 5
• 208000020016 psychiatric disease Diseases 0.000 claims description 5
• 208000002815 pulmonary hypertension Diseases 0.000 claims description 5
• 210000002345 respiratory system Anatomy 0.000 claims description 5
• 230000035882 stress Effects 0.000 claims description 5
• 238000002627 tracheal intubation Methods 0.000 claims description 5
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 5
• 230000024883 vasodilation Effects 0.000 claims description 5
• 241000711573 Coronaviridae Species 0.000 claims description 4
• 201000005569 Gout Diseases 0.000 claims description 4
• 201000009906 Meningitis Diseases 0.000 claims description 4
• 230000006735 deficit Effects 0.000 claims description 4
• 230000008021 deposition Effects 0.000 claims description 4
• 235000003599 food sweetener Nutrition 0.000 claims description 4
• 239000012729 immediate-release (IR) formulation Substances 0.000 claims description 4
• 230000002757 inflammatory effect Effects 0.000 claims description 4
• 206010022000 influenza Diseases 0.000 claims description 4
• 238000005342 ion exchange Methods 0.000 claims description 4
• 239000004005 microsphere Substances 0.000 claims description 4
• 210000004083 nasolacrimal duct Anatomy 0.000 claims description 4
• 206010041232 sneezing Diseases 0.000 claims description 4
• 239000003765 sweetening agent Substances 0.000 claims description 4
• 241000709661 Enterovirus Species 0.000 claims description 3
• 241000588724 Escherichia coli Species 0.000 claims description 3
• 206010019196 Head injury Diseases 0.000 claims description 3
• 206010028980 Neoplasm Diseases 0.000 claims description 3
• 241000700605 Viruses Species 0.000 claims description 3
• 239000013566 allergen Substances 0.000 claims description 3
• 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
• 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
• 230000006931 brain damage Effects 0.000 claims description 3
• 231100000874 brain damage Toxicity 0.000 claims description 3
• 208000029028 brain injury Diseases 0.000 claims description 3
• 201000011510 cancer Diseases 0.000 claims description 3
• 238000000576 coating method Methods 0.000 claims description 3
• 239000000850 decongestant Substances 0.000 claims description 3
• 229940124581 decongestants Drugs 0.000 claims description 3
• 230000003412 degenerative effect Effects 0.000 claims description 3
• 238000001839 endoscopy Methods 0.000 claims description 3
• 230000008753 endothelial function Effects 0.000 claims description 3
• 239000002532 enzyme inhibitor Substances 0.000 claims description 3
• 230000028709 inflammatory response Effects 0.000 claims description 3
• 210000004086 maxillary sinus Anatomy 0.000 claims description 3
• 210000001989 nasopharynx Anatomy 0.000 claims description 3
• 230000000069 prophylactic effect Effects 0.000 claims description 3
• 230000028624 response to insect Effects 0.000 claims description 3
• 208000020431 spinal cord injury Diseases 0.000 claims description 3
• 206010056370 Congestive cardiomyopathy Diseases 0.000 claims description 2
• 201000010046 Dilated cardiomyopathy Diseases 0.000 claims description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 claims description 2
• 241000192147 Nitrosococcus Species 0.000 claims description 2
• 241000605120 Nitrosomonas eutropha Species 0.000 claims description 2
• 241000192123 Nitrosovibrio Species 0.000 claims description 2
• 206010039710 Scleroderma Diseases 0.000 claims description 2
• 239000003463 adsorbent Substances 0.000 claims description 2
• 238000013459 approach Methods 0.000 claims description 2
• 239000011248 coating agent Substances 0.000 claims description 2
• 238000012377 drug delivery Methods 0.000 claims description 2
• 210000000750 endocrine system Anatomy 0.000 claims description 2
• 208000016361 genetic disease Diseases 0.000 claims description 2
• 238000001802 infusion Methods 0.000 claims description 2
• 230000000977 initiatory effect Effects 0.000 claims description 2
• 208000028867 ischemia Diseases 0.000 claims description 2
• 230000000302 ischemic effect Effects 0.000 claims description 2
• 238000007726 management method Methods 0.000 claims description 2
• 239000007923 nasal drop Substances 0.000 claims description 2
• 230000001272 neurogenic effect Effects 0.000 claims description 2
• 230000002335 preservative effect Effects 0.000 claims description 2
• 239000006041 probiotic Substances 0.000 claims description 2
• 235000018291 probiotics Nutrition 0.000 claims description 2
• 238000007627 surgical diagnostic procedure Methods 0.000 claims description 2
• 230000002792 vascular Effects 0.000 claims description 2
• 238000005406 washing Methods 0.000 claims description 2
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
• 208000031226 Hyperlipidaemia Diseases 0.000 claims 3
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
• 239000002253 acid Substances 0.000 claims 2
• 230000004064 dysfunction Effects 0.000 claims 2
• 208000031229 Cardiomyopathies Diseases 0.000 claims 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
• 206010039897 Sedation Diseases 0.000 claims 1
• 235000002597 Solanum melongena Nutrition 0.000 claims 1
• 244000061458 Solanum melongena Species 0.000 claims 1
• 206010047141 Vasodilatation Diseases 0.000 claims 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
• 229940125532 enzyme inhibitor Drugs 0.000 claims 1
• 235000013355 food flavoring agent Nutrition 0.000 claims 1
• 239000011777 magnesium Substances 0.000 claims 1
• 229910052749 magnesium Inorganic materials 0.000 claims 1
• 230000002175 menstrual effect Effects 0.000 claims 1
• 210000004400 mucous membrane Anatomy 0.000 claims 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
• 238000011321 prophylaxis Methods 0.000 claims 1
• 230000036280 sedation Effects 0.000 claims 1
• 208000027866 inflammatory disease Diseases 0.000 abstract description 11
• 239000007800 oxidant agent Substances 0.000 abstract description 3
• 239000000047 product Substances 0.000 description 94
• 239000002537 cosmetic Substances 0.000 description 61
• 241001453382 Nitrosomonadales Species 0.000 description 60
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 47
• 210000004209 hair Anatomy 0.000 description 30
• 230000001225 therapeutic effect Effects 0.000 description 28
• 229930014626 natural product Natural products 0.000 description 26
• 239000013543 active substance Substances 0.000 description 21
• 210000003491 skin Anatomy 0.000 description 21
• 241000282414 Homo sapiens Species 0.000 description 20
• 239000006210 lotion Substances 0.000 description 20
• 208000024891 symptom Diseases 0.000 description 20
• 239000003921 oil Substances 0.000 description 16
• 239000000344 soap Substances 0.000 description 16
• 239000003599 detergent Substances 0.000 description 14
• 235000019198 oils Nutrition 0.000 description 14
• 235000018102 proteins Nutrition 0.000 description 14
• 239000007787 solid Substances 0.000 description 14
• 238000006243 chemical reaction Methods 0.000 description 13
• 238000007254 oxidation reaction Methods 0.000 description 13
• 239000002453 shampoo Substances 0.000 description 13
• 241001465754 Metazoa Species 0.000 description 12
• 239000006071 cream Substances 0.000 description 12
• 210000003298 dental enamel Anatomy 0.000 description 12
• 239000003814 drug Substances 0.000 description 12
• 230000003647 oxidation Effects 0.000 description 12
• 239000002245 particle Substances 0.000 description 12
• 229940079593 drug Drugs 0.000 description 11
• 239000004615 ingredient Substances 0.000 description 11
• 239000006227 byproduct Substances 0.000 description 10
• 230000035772 mutation Effects 0.000 description 10
• 239000004480 active ingredient Substances 0.000 description 9
• 230000001651 autotrophic effect Effects 0.000 description 9
• 230000008901 benefit Effects 0.000 description 9
• 239000002781 deodorant agent Substances 0.000 description 9
• 239000000118 hair dye Substances 0.000 description 9
• 230000000813 microbial effect Effects 0.000 description 9
• 239000002304 perfume Substances 0.000 description 9
• 239000000758 substrate Substances 0.000 description 9
• 239000003826 tablet Substances 0.000 description 9
• 239000002775 capsule Substances 0.000 description 8
• 229920000642 polymer Polymers 0.000 description 8
• 235000002639 sodium chloride Nutrition 0.000 description 8
• 239000000454 talc Substances 0.000 description 8
• 235000012222 talc Nutrition 0.000 description 8
• 229910052623 talc Inorganic materials 0.000 description 8
• 210000004027 cell Anatomy 0.000 description 7
• 239000012530 fluid Substances 0.000 description 7
• 239000002324 mouth wash Substances 0.000 description 7
• 230000035899 viability Effects 0.000 description 7
• 239000000080 wetting agent Substances 0.000 description 7
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
• 229920002125 Sokalan® Polymers 0.000 description 6
• 229920002472 Starch Polymers 0.000 description 6
• 239000003570 air Substances 0.000 description 6
• 230000009286 beneficial effect Effects 0.000 description 6
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
• 230000036541 health Effects 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 230000000670 limiting effect Effects 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 229940051866 mouthwash Drugs 0.000 description 6
• 231100000350 mutagenesis Toxicity 0.000 description 6
• 235000015097 nutrients Nutrition 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 230000001105 regulatory effect Effects 0.000 description 6
• 238000002741 site-directed mutagenesis Methods 0.000 description 6
• 241000894007 species Species 0.000 description 6
• 239000008107 starch Substances 0.000 description 6
• 229940032147 starch Drugs 0.000 description 6
• 235000019698 starch Nutrition 0.000 description 6
• 241000124008 Mammalia Species 0.000 description 5
• 239000004909 Moisturizer Substances 0.000 description 5
• 206010052428 Wound Diseases 0.000 description 5
• 208000027418 Wounds and injury Diseases 0.000 description 5
• 230000003110 anti-inflammatory effect Effects 0.000 description 5
• 235000006708 antioxidants Nutrition 0.000 description 5
• 239000007864 aqueous solution Substances 0.000 description 5
• 244000052616 bacterial pathogen Species 0.000 description 5
• MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 5
• 229940073507 cocamidopropyl betaine Drugs 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 239000003085 diluting agent Substances 0.000 description 5
• 239000006185 dispersion Substances 0.000 description 5
• 239000003937 drug carrier Substances 0.000 description 5
• 239000003349 gelling agent Substances 0.000 description 5
• 238000007918 intramuscular administration Methods 0.000 description 5
• 230000001333 moisturizer Effects 0.000 description 5
• 238000002703 mutagenesis Methods 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 239000006072 paste Substances 0.000 description 5
• 230000001717 pathogenic effect Effects 0.000 description 5
• 108090000765 processed proteins & peptides Proteins 0.000 description 5
• 102000004196 processed proteins & peptides Human genes 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 229940057950 sodium laureth sulfate Drugs 0.000 description 5
• SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 208000035985 Body Odor Diseases 0.000 description 4
• 229920000858 Cyclodextrin Polymers 0.000 description 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 206010040904 Skin odour abnormal Diseases 0.000 description 4
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 235000010443 alginic acid Nutrition 0.000 description 4
• 229920000615 alginic acid Polymers 0.000 description 4
• 125000000217 alkyl group Chemical group 0.000 description 4
• 229940035676 analgesics Drugs 0.000 description 4
• 208000010668 atopic eczema Diseases 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 4
• 239000003788 bath preparation Substances 0.000 description 4
• 239000000227 bioadhesive Substances 0.000 description 4
• 239000006172 buffering agent Substances 0.000 description 4
• 239000001768 carboxy methyl cellulose Substances 0.000 description 4
• GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
• 238000002405 diagnostic procedure Methods 0.000 description 4
• 230000002708 enhancing effect Effects 0.000 description 4
• 210000003608 fece Anatomy 0.000 description 4
• 235000019634 flavors Nutrition 0.000 description 4
• 239000008187 granular material Substances 0.000 description 4
• 239000003676 hair preparation Substances 0.000 description 4
• 239000008266 hair spray Substances 0.000 description 4
• 210000004247 hand Anatomy 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 4
• 229940048848 lauryl glucoside Drugs 0.000 description 4
• 210000004877 mucosa Anatomy 0.000 description 4
• 210000003739 neck Anatomy 0.000 description 4
• 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 4
• 231100000252 nontoxic Toxicity 0.000 description 4
• 230000003000 nontoxic effect Effects 0.000 description 4
• 150000002894 organic compounds Chemical class 0.000 description 4
• 239000000123 paper Substances 0.000 description 4
• 230000035479 physiological effects, processes and functions Effects 0.000 description 4
• 239000004584 polyacrylic acid Substances 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 108091033319 polynucleotide Proteins 0.000 description 4
• 102000040430 polynucleotide Human genes 0.000 description 4
• 239000002157 polynucleotide Substances 0.000 description 4
• 150000003839 salts Chemical class 0.000 description 4
• 239000002437 shaving preparation Substances 0.000 description 4
• 239000007909 solid dosage form Substances 0.000 description 4
• 239000000829 suppository Substances 0.000 description 4
• 230000002195 synergetic effect Effects 0.000 description 4
• 235000015961 tonic Nutrition 0.000 description 4
• 230000001256 tonic effect Effects 0.000 description 4
• 229960000716 tonics Drugs 0.000 description 4
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 108010061397 Ammonia monooxygenase Proteins 0.000 description 3
• 241000203069 Archaea Species 0.000 description 3
• WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
• 229920001661 Chitosan Polymers 0.000 description 3
• 201000004624 Dermatitis Diseases 0.000 description 3
• 241000196324 Embryophyta Species 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 239000004698 Polyethylene Substances 0.000 description 3
• 239000002202 Polyethylene glycol Substances 0.000 description 3
• 208000003251 Pruritus Diseases 0.000 description 3
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 230000000996 additive effect Effects 0.000 description 3
• 239000003833 bile salt Substances 0.000 description 3
• 230000008499 blood brain barrier function Effects 0.000 description 3
• 210000001218 blood-brain barrier Anatomy 0.000 description 3
• 239000001569 carbon dioxide Substances 0.000 description 3
• 229910002092 carbon dioxide Inorganic materials 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 229940045110 chitosan Drugs 0.000 description 3
• 230000037326 chronic stress Effects 0.000 description 3
• 239000003240 coconut oil Substances 0.000 description 3
• 235000019864 coconut oil Nutrition 0.000 description 3
• 235000017471 coenzyme Q10 Nutrition 0.000 description 3
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
• 230000002951 depilatory effect Effects 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 206010012601 diabetes mellitus Diseases 0.000 description 3
• 239000002270 dispersing agent Substances 0.000 description 3
• 239000003995 emulsifying agent Substances 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 210000004709 eyebrow Anatomy 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 230000003370 grooming effect Effects 0.000 description 3
• 230000037308 hair color Effects 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 239000000077 insect repellent Substances 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 230000007794 irritation Effects 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 230000014759 maintenance of location Effects 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 150000007523 nucleic acids Chemical group 0.000 description 3
• 239000002773 nucleotide Substances 0.000 description 3
• 125000003729 nucleotide group Chemical group 0.000 description 3
• 239000006179 pH buffering agent Substances 0.000 description 3
• 239000003973 paint Substances 0.000 description 3
• 229920000573 polyethylene Polymers 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 230000001737 promoting effect Effects 0.000 description 3
• 235000021251 pulses Nutrition 0.000 description 3
• 230000000241 respiratory effect Effects 0.000 description 3
• 239000008257 shaving cream Substances 0.000 description 3
• 239000001632 sodium acetate Substances 0.000 description 3
• 235000017281 sodium acetate Nutrition 0.000 description 3
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
• 239000001488 sodium phosphate Substances 0.000 description 3
• 229910000162 sodium phosphate Inorganic materials 0.000 description 3
• 239000003381 stabilizer Substances 0.000 description 3
• 150000003431 steroids Chemical class 0.000 description 3
• 239000013589 supplement Substances 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 229940034610 toothpaste Drugs 0.000 description 3
• 239000000606 toothpaste Substances 0.000 description 3
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
• MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
• WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
• XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
• 230000002407 ATP formation Effects 0.000 description 2
• 208000002874 Acne Vulgaris Diseases 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
• 101100137343 Arabidopsis thaliana PPCS1 gene Proteins 0.000 description 2
• 241000238421 Arthropoda Species 0.000 description 2
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
• 208000011231 Crohn disease Diseases 0.000 description 2
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
• 208000003105 Diaper Rash Diseases 0.000 description 2
• 241000792859 Enema Species 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 206010016936 Folliculitis Diseases 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• 229920002907 Guar gum Polymers 0.000 description 2
• 101100191163 Homo sapiens PPCS gene Proteins 0.000 description 2
• 102000008100 Human Serum Albumin Human genes 0.000 description 2
• 108091006905 Human Serum Albumin Proteins 0.000 description 2
• 241000701806 Human papillomavirus Species 0.000 description 2
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 229930195725 Mannitol Natural products 0.000 description 2
• 241000205276 Methanosarcina Species 0.000 description 2
• 241000736262 Microbiota Species 0.000 description 2
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
• 208000022873 Ocular disease Diseases 0.000 description 2
• 208000002193 Pain Diseases 0.000 description 2
• 102100022923 Phosphopantothenate-cysteine ligase Human genes 0.000 description 2
• RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
• 239000000589 Siderophore Substances 0.000 description 2
• 241000282898 Sus scrofa Species 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 240000008042 Zea mays Species 0.000 description 2
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 206010000496 acne Diseases 0.000 description 2
• 230000037328 acute stress Effects 0.000 description 2
• 229960005305 adenosine Drugs 0.000 description 2
• 208000009736 adult acne Diseases 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 208000037883 airway inflammation Diseases 0.000 description 2
• 229940072056 alginate Drugs 0.000 description 2
• 239000000783 alginic acid Substances 0.000 description 2
• 229960001126 alginic acid Drugs 0.000 description 2
• 150000004781 alginic acids Chemical class 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 229920006125 amorphous polymer Polymers 0.000 description 2
• 239000003945 anionic surfactant Substances 0.000 description 2
• 239000004599 antimicrobial Substances 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 238000003287 bathing Methods 0.000 description 2
• 229940093761 bile salts Drugs 0.000 description 2
• 229920002988 biodegradable polymer Polymers 0.000 description 2
• 239000004621 biodegradable polymer Substances 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 210000001124 body fluid Anatomy 0.000 description 2
• 239000004067 bulking agent Substances 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
• 229940105329 carboxymethylcellulose Drugs 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 230000001886 ciliary effect Effects 0.000 description 2
• 229960004106 citric acid Drugs 0.000 description 2
• 235000015165 citric acid Nutrition 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 239000000571 coke Substances 0.000 description 2
• 235000005822 corn Nutrition 0.000 description 2
• 239000003246 corticosteroid Substances 0.000 description 2
• 229960001334 corticosteroids Drugs 0.000 description 2
• 229940097362 cyclodextrins Drugs 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 235000015872 dietary supplement Nutrition 0.000 description 2
• LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical class CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
• 239000007920 enema Substances 0.000 description 2
• 229940088598 enzyme Drugs 0.000 description 2
• 210000001723 extracellular space Anatomy 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 235000019197 fats Nutrition 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 150000004665 fatty acids Chemical class 0.000 description 2
• 239000006260 foam Substances 0.000 description 2
• 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
• 238000009499 grossing Methods 0.000 description 2
• 235000010417 guar gum Nutrition 0.000 description 2
• 239000000665 guar gum Substances 0.000 description 2
• 229960002154 guar gum Drugs 0.000 description 2
• 230000009931 harmful effect Effects 0.000 description 2
• 239000010460 hemp oil Substances 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000000338 in vitro Methods 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• 239000003456 ion exchange resin Substances 0.000 description 2
• 229920003303 ion-exchange polymer Polymers 0.000 description 2
• 230000002262 irrigation Effects 0.000 description 2
• 238000003973 irrigation Methods 0.000 description 2
• 230000007803 itching Effects 0.000 description 2
• 229940119170 jojoba wax Drugs 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 239000000594 mannitol Substances 0.000 description 2
• 235000010355 mannitol Nutrition 0.000 description 2
• 210000004379 membrane Anatomy 0.000 description 2
• 239000012528 membrane Substances 0.000 description 2
• 230000005499 meniscus Effects 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 230000037353 metabolic pathway Effects 0.000 description 2
• 244000000010 microbial pathogen Species 0.000 description 2
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
• 239000008108 microcrystalline cellulose Substances 0.000 description 2
• 229940016286 microcrystalline cellulose Drugs 0.000 description 2
• 239000002480 mineral oil Substances 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• 230000000926 neurological effect Effects 0.000 description 2
• 239000002736 nonionic surfactant Substances 0.000 description 2
• 210000001331 nose Anatomy 0.000 description 2
• 235000019645 odor Nutrition 0.000 description 2
• 239000004006 olive oil Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 230000035699 permeability Effects 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229960000502 poloxamer Drugs 0.000 description 2
• 229920001983 poloxamer Polymers 0.000 description 2
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 150000004804 polysaccharides Chemical class 0.000 description 2
• 229920000053 polysorbate 80 Polymers 0.000 description 2
• 239000011148 porous material Substances 0.000 description 2
• 229910001414 potassium ion Inorganic materials 0.000 description 2
• 230000011514 reflex Effects 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
• 239000013535 sea water Substances 0.000 description 2
• 238000007493 shaping process Methods 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 235000010413 sodium alginate Nutrition 0.000 description 2
• 239000000661 sodium alginate Substances 0.000 description 2
• 229940005550 sodium alginate Drugs 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
• 229940007636 sodium lauroyl methyl isethionate Drugs 0.000 description 2
• NVIZQHFCDBQNPH-UHFFFAOYSA-M sodium;2-dodecanoyloxypropane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)CS([O-])(=O)=O NVIZQHFCDBQNPH-UHFFFAOYSA-M 0.000 description 2
• 230000003381 solubilizing effect Effects 0.000 description 2
• 229940035044 sorbitan monolaurate Drugs 0.000 description 2
• 230000002269 spontaneous effect Effects 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 239000012536 storage buffer Substances 0.000 description 2
• 238000009121 systemic therapy Methods 0.000 description 2
• 150000003505 terpenes Chemical group 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 239000011732 tocopherol Substances 0.000 description 2
• 229930003799 tocopherol Natural products 0.000 description 2
• 235000010384 tocopherol Nutrition 0.000 description 2
• 229960001295 tocopherol Drugs 0.000 description 2
• 238000011200 topical administration Methods 0.000 description 2
• 239000012049 topical pharmaceutical composition Substances 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 239000011573 trace mineral Substances 0.000 description 2
• 235000013619 trace mineral Nutrition 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 230000009261 transgenic effect Effects 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• 230000001720 vestibular Effects 0.000 description 2
• 230000003612 virological effect Effects 0.000 description 2
• 239000002699 waste material Substances 0.000 description 2
• 238000009736 wetting Methods 0.000 description 2
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
• NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
• WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
• 108020004465 16S ribosomal RNA Proteins 0.000 description 1
• CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 1
• LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
• WQPMYSHJKXVTME-UHFFFAOYSA-N 3-hydroxypropane-1-sulfonic acid Chemical compound OCCCS(O)(=O)=O WQPMYSHJKXVTME-UHFFFAOYSA-N 0.000 description 1
• HYCSHFLKPSMPGO-UHFFFAOYSA-N 3-hydroxypropyl dihydrogen phosphate Chemical compound OCCCOP(O)(O)=O HYCSHFLKPSMPGO-UHFFFAOYSA-N 0.000 description 1
• IDLSITKDRVDKRV-JSUROZADSA-N 4-[2-[[(1s,2r)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol;hydrochloride Chemical compound Cl.N([C@H](C)[C@@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IDLSITKDRVDKRV-JSUROZADSA-N 0.000 description 1
• BUADUHVXMFJVLH-UHFFFAOYSA-N 7-chloro-3-imidazol-1-yl-2H-1,2,4-benzotriazin-1-ium 1-oxide Chemical compound N1[N+](=O)C2=CC(Cl)=CC=C2N=C1N1C=CN=C1 BUADUHVXMFJVLH-UHFFFAOYSA-N 0.000 description 1
• QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
• 206010000503 Acne cystic Diseases 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 241001116389 Aloe Species 0.000 description 1
• 201000004384 Alopecia Diseases 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 240000003291 Armoracia rusticana Species 0.000 description 1
• 235000011330 Armoracia rusticana Nutrition 0.000 description 1
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
• 229930003347 Atropine Natural products 0.000 description 1
• 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
• 239000004604 Blowing Agent Substances 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241001235325 Candidatus Caldiarchaeum subterraneum Species 0.000 description 1
• 241000057211 Candidatus Giganthauma insulaporcus Species 0.000 description 1
• 241000057209 Candidatus Giganthauma karukerense Species 0.000 description 1
• 241000630165 Candidatus Nitrososphaera gargensis Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 241000205387 Cenarchaeum symbiosum Species 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 1
• 241001137853 Crenarchaeota Species 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 208000014997 Crohn colitis Diseases 0.000 description 1
• 102100030497 Cytochrome c Human genes 0.000 description 1
• 101710194084 Cytochrome c-554 Proteins 0.000 description 1
• 108010075031 Cytochromes c Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
• 108020004414 DNA Proteins 0.000 description 1
• 241000193880 Demodex folliculorum Species 0.000 description 1
• 206010012442 Dermatitis contact Diseases 0.000 description 1
• 206010012444 Dermatitis diaper Diseases 0.000 description 1
• 206010056340 Diabetic ulcer Diseases 0.000 description 1
• 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 208000010228 Erectile Dysfunction Diseases 0.000 description 1
• 241001137858 Euryarchaeota Species 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 239000001116 FEMA 4028 Substances 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 208000003790 Foot Ulcer Diseases 0.000 description 1
• IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
• 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
• 229920002148 Gellan gum Polymers 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 208000010412 Glaucoma Diseases 0.000 description 1
• 108010068370 Glutens Proteins 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
• 206010058898 Hand dermatitis Diseases 0.000 description 1
• 208000037319 Hepatitis infectious Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
• 208000008454 Hyperhidrosis Diseases 0.000 description 1
• 206010020649 Hyperkeratosis Diseases 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010021519 Impaired healing Diseases 0.000 description 1
• 206010021639 Incontinence Diseases 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102000016924 KATP Channels Human genes 0.000 description 1
• 108010053914 KATP Channels Proteins 0.000 description 1
• 208000001126 Keratosis Diseases 0.000 description 1
• 241000186660 Lactobacillus Species 0.000 description 1
• 201000008197 Laryngitis Diseases 0.000 description 1
• 206010024229 Leprosy Diseases 0.000 description 1
• 229920000161 Locust bean gum Polymers 0.000 description 1
• 241000202987 Methanobrevibacter Species 0.000 description 1
• 241000204677 Methanosphaera Species 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 206010051606 Necrotising colitis Diseases 0.000 description 1
• 206010060860 Neurological symptom Diseases 0.000 description 1
• 102100022397 Nitric oxide synthase, brain Human genes 0.000 description 1
• 101710111444 Nitric oxide synthase, brain Proteins 0.000 description 1
• 241000402149 Nitrosopumilus Species 0.000 description 1
• 241000630164 Nitrososphaera Species 0.000 description 1
• 241000995838 Nitrososphaera viennensis Species 0.000 description 1
• 239000005642 Oleic acid Substances 0.000 description 1
• ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 235000019482 Palm oil Nutrition 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 229920000388 Polyphosphate Polymers 0.000 description 1
• 102000004257 Potassium Channel Human genes 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000003782 Raynaud disease Diseases 0.000 description 1
• 208000012322 Raynaud phenomenon Diseases 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 206010039792 Seborrhoea Diseases 0.000 description 1
• 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
• 206010041925 Staphylococcal infections Diseases 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 206010042496 Sunburn Diseases 0.000 description 1
• OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
• 206010043269 Tension headache Diseases 0.000 description 1
• 241000170370 Thaumarchaeota Species 0.000 description 1
• 229920002807 Thiomer Polymers 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 208000003443 Unconsciousness Diseases 0.000 description 1
• 208000037009 Vaginitis bacterial Diseases 0.000 description 1
• 229930003427 Vitamin E Natural products 0.000 description 1
• 206010047700 Vomiting Diseases 0.000 description 1
• 210000000683 abdominal cavity Anatomy 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 239000000556 agonist Substances 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 235000011399 aloe vera Nutrition 0.000 description 1
• 231100000360 alopecia Toxicity 0.000 description 1
• 125000003275 alpha amino acid group Chemical group 0.000 description 1
• 239000012080 ambient air Substances 0.000 description 1
• LDPIQRWHBLWKPR-UHFFFAOYSA-N aminoboronic acid Chemical class NB(O)O LDPIQRWHBLWKPR-UHFFFAOYSA-N 0.000 description 1
• 235000019270 ammonium chloride Nutrition 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 230000000202 analgesic effect Effects 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000003712 anti-aging effect Effects 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000002519 antifouling agent Substances 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000008365 aqueous carrier Substances 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
• 229960000396 atropine Drugs 0.000 description 1
• 210000003578 bacterial chromosome Anatomy 0.000 description 1
• 239000003899 bactericide agent Substances 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 235000019445 benzyl alcohol Nutrition 0.000 description 1
• 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
• 229960004853 betadex Drugs 0.000 description 1
• 229960003237 betaine Drugs 0.000 description 1
• 230000035587 bioadhesion Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 208000010217 blepharitis Diseases 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 210000004369 blood Anatomy 0.000 description 1
• 239000008280 blood Substances 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 230000036770 blood supply Effects 0.000 description 1
• 238000007664 blowing Methods 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 239000011111 cardboard Substances 0.000 description 1
• 235000010418 carrageenan Nutrition 0.000 description 1
• 239000000679 carrageenan Substances 0.000 description 1
• 229920001525 carrageenan Polymers 0.000 description 1
• 229940113118 carrageenan Drugs 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 239000003093 cationic surfactant Substances 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000002812 cholic acid derivative Substances 0.000 description 1
• 210000000254 ciliated cell Anatomy 0.000 description 1
• 239000004927 clay Substances 0.000 description 1
• 229910052570 clay Inorganic materials 0.000 description 1
• 239000012459 cleaning agent Substances 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 210000001520 comb Anatomy 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 208000010247 contact dermatitis Diseases 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 229960003964 deoxycholic acid Drugs 0.000 description 1
• 201000001981 dermatomyositis Diseases 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
• 229940038472 dicalcium phosphate Drugs 0.000 description 1
• 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 239000013583 drug formulation Substances 0.000 description 1
• 238000010410 dusting Methods 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 239000003221 ear drop Substances 0.000 description 1
• 229940047652 ear drops Drugs 0.000 description 1
• QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 229940095399 enema Drugs 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 229960003720 enoxolone Drugs 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 239000004318 erythorbic acid Substances 0.000 description 1
• 235000010350 erythorbic acid Nutrition 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
• 210000003414 extremity Anatomy 0.000 description 1
• 239000003889 eye drop Substances 0.000 description 1
• 229940012356 eye drops Drugs 0.000 description 1
• 230000001815 facial effect Effects 0.000 description 1
• 239000010408 film Substances 0.000 description 1
• 238000010579 first pass effect Methods 0.000 description 1
• 238000005187 foaming Methods 0.000 description 1
• 239000004088 foaming agent Substances 0.000 description 1
• 235000013373 food additive Nutrition 0.000 description 1
• 239000002778 food additive Substances 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 235000013376 functional food Nutrition 0.000 description 1
• UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
• IECPWNUMDGFDKC-MZJAQBGESA-M fusidate Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-M 0.000 description 1
• 229960004675 fusidic acid Drugs 0.000 description 1
• ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
• WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 235000010492 gellan gum Nutrition 0.000 description 1
• 239000000216 gellan gum Substances 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 208000017533 genetic nervous system disease Diseases 0.000 description 1
• 235000021312 gluten Nutrition 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 235000011187 glycerol Nutrition 0.000 description 1
• LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
• 230000008821 health effect Effects 0.000 description 1
• 230000036074 healthy skin Effects 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 208000024798 heartburn Diseases 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 239000003906 humectant Substances 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000036571 hydration Effects 0.000 description 1
• 238000006703 hydration reaction Methods 0.000 description 1
• 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 230000037315 hyperhidrosis Effects 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 206010021247 idiopathic urticaria Diseases 0.000 description 1
• 230000002134 immunopathologic effect Effects 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 201000001881 impotence Diseases 0.000 description 1
• 238000005470 impregnation Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 229910010272 inorganic material Inorganic materials 0.000 description 1
• 239000011147 inorganic material Substances 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 208000028774 intestinal disease Diseases 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 239000000797 iron chelating agent Substances 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 231100000021 irritant Toxicity 0.000 description 1
• 230000000622 irritating effect Effects 0.000 description 1
• 229940026239 isoascorbic acid Drugs 0.000 description 1
• QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
• 235000015110 jellies Nutrition 0.000 description 1
• 239000008274 jelly Substances 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 229940039696 lactobacillus Drugs 0.000 description 1
• 229920005610 lignin Polymers 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 239000012669 liquid formulation Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 235000010420 locust bean gum Nutrition 0.000 description 1
• 239000000711 locust bean gum Substances 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 229940057948 magnesium stearate Drugs 0.000 description 1
• 239000003550 marker Substances 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 230000005541 medical transmission Effects 0.000 description 1
• 230000028161 membrane depolarization Effects 0.000 description 1
• 229940041616 menthol Drugs 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 229940073769 methyl oleate Drugs 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 229960002900 methylcellulose Drugs 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 235000010755 mineral Nutrition 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 230000008437 mitochondrial biogenesis Effects 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 229940097496 nasal spray Drugs 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 230000001123 neurodevelopmental effect Effects 0.000 description 1
• 239000002353 niosome Substances 0.000 description 1
• 150000002823 nitrates Chemical class 0.000 description 1
• 150000002826 nitrites Chemical class 0.000 description 1
• 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 1
• 231100000344 non-irritating Toxicity 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1
• 230000009965 odorless effect Effects 0.000 description 1
• 230000037312 oily skin Effects 0.000 description 1
• ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
• 210000002475 olfactory pathway Anatomy 0.000 description 1
• 229940126701 oral medication Drugs 0.000 description 1
• 239000011368 organic material Substances 0.000 description 1
• 230000000399 orthopedic effect Effects 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• GSWAOPJLTADLTN-UHFFFAOYSA-N oxidanimine Chemical compound [O-][NH3+] GSWAOPJLTADLTN-UHFFFAOYSA-N 0.000 description 1
• 238000010525 oxidative degradation reaction Methods 0.000 description 1
• 230000036284 oxygen consumption Effects 0.000 description 1
• 239000003346 palm kernel oil Substances 0.000 description 1
• 235000019865 palm kernel oil Nutrition 0.000 description 1
• 239000002540 palm oil Substances 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 208000008494 pericarditis Diseases 0.000 description 1
• 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 229930015704 phenylpropanoid Natural products 0.000 description 1
• 125000001474 phenylpropanoid group Chemical group 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000002953 phosphate buffered saline Substances 0.000 description 1
• 238000010672 photosynthesis Methods 0.000 description 1
• 230000029553 photosynthesis Effects 0.000 description 1
• 239000006069 physical mixture Substances 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 229930001119 polyketide Natural products 0.000 description 1
• 125000000830 polyketide group Chemical group 0.000 description 1
• 239000001205 polyphosphate Substances 0.000 description 1
• 235000011176 polyphosphates Nutrition 0.000 description 1
• 108020001213 potassium channel Proteins 0.000 description 1
• 229930010796 primary metabolite Natural products 0.000 description 1
• 201000000742 primary sclerosing cholangitis Diseases 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 230000004224 protection Effects 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 238000003908 quality control method Methods 0.000 description 1
• 238000012372 quality testing Methods 0.000 description 1
• 238000010791 quenching Methods 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000008327 renal blood flow Effects 0.000 description 1
• 238000013468 resource allocation Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 210000004761 scalp Anatomy 0.000 description 1
• 208000010157 sclerosing cholangitis Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 208000008742 seborrheic dermatitis Diseases 0.000 description 1
• 201000003779 seborrheic infantile dermatitis Diseases 0.000 description 1
• 229930000044 secondary metabolite Natural products 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 229920002545 silicone oil Polymers 0.000 description 1
• 230000037384 skin absorption Effects 0.000 description 1
• 231100000274 skin absorption Toxicity 0.000 description 1
• 230000037075 skin appearance Effects 0.000 description 1
• 230000036559 skin health Effects 0.000 description 1
• 230000036555 skin type Effects 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
• FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
• OABYVIYXWMZFFJ-ZUHYDKSRSA-M sodium glycocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 OABYVIYXWMZFFJ-ZUHYDKSRSA-M 0.000 description 1
• 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
• 159000000000 sodium salts Chemical class 0.000 description 1
• JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
• HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 239000007962 solid dispersion Substances 0.000 description 1
• 239000008137 solubility enhancer Substances 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 208000023516 stroke disease Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 230000000475 sunscreen effect Effects 0.000 description 1
• 239000000516 sunscreening agent Substances 0.000 description 1
• 230000000153 supplemental effect Effects 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 210000004243 sweat Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000001839 systemic circulation Effects 0.000 description 1
• 238000012385 systemic delivery Methods 0.000 description 1
• 229940104261 taurate Drugs 0.000 description 1
• XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 229910021654 trace metal Inorganic materials 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
• LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 1
• 239000005436 troposphere Substances 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 230000000304 vasodilatating effect Effects 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 230000001018 virulence Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 235000019165 vitamin E Nutrition 0.000 description 1
• 239000011709 vitamin E Substances 0.000 description 1
• 229940046009 vitamin E Drugs 0.000 description 1
• 230000008673 vomiting Effects 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 210000000707 wrist Anatomy 0.000 description 1
• 229920001285 xanthan gum Polymers 0.000 description 1
• 235000010493 xanthan gum Nutrition 0.000 description 1
• 239000000230 xanthan gum Substances 0.000 description 1
• 229940082509 xanthan gum Drugs 0.000 description 1
• 239000011787 zinc oxide Substances 0.000 description 1
• UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
• 239000002888 zwitterionic surfactant Substances 0.000 description 1